Document Detail


Stroke prevention: is it possible? If so, which antihypertensive agent should be used?
MedLine Citation:
PMID:  13678484     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The importance of blood pressure control in stroke prevention is supported by a large body of clinical evidence. However, it is not known which antihypertensive agents are most effective in preventing stroke. As stroke is characterised by vascular remodelling and dysfunction and by effects on the cerebral circulation, selecting an agent that has a direct vascular protective effect beyond blood pressure control may be desirable. Results with the angiotensin receptor blockers (ARBs) in clinical trials (LIFE and SCOPE) support the findings in animal models that ARBs may be a promising therapeutic option for prevention of stroke and possibly, cognitive decline.
Authors:
Shokei Kim
Related Documents :
12778994 - Chart review and pilot study of blood pressure control in acute ischemic stroke.
1555854 - An automatic control algorithm for the optimal driving of the ventricular-assist device.
21055854 - Between-limb synchronization for control of standing balance in individuals with stroke.
24067344 - Enhancement of superconductivity near the pressure-induced semiconductor-metal transiti...
18717974 - Microvascular disease: what does the ukpds tell us about diabetic retinopathy?
18408124 - Wave reflection augments central systolic and pulse pressures during facial cooling.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current medical research and opinion     Volume:  19     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  2003  
Date Detail:
Created Date:  2003-09-18     Completed Date:  2004-03-24     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  England    
Other Details:
Languages:  eng     Pagination:  442-4     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin Receptor Antagonists*
Animals
Antihypertensive Agents / pharmacology,  therapeutic use*
Benzimidazoles / pharmacology,  therapeutic use*
Cerebrovascular Circulation / drug effects
Humans
Hypertension / prevention & control
Losartan / pharmacology,  therapeutic use*
Rats
Rats, Inbred SHR
Stroke / prevention & control*
Tetrazoles / pharmacology,  therapeutic use*
Chemical
Reg. No./Substance:
0/Angiotensin Receptor Antagonists; 0/Antihypertensive Agents; 0/Benzimidazoles; 0/Tetrazoles; 114798-26-4/Losartan; S8Q36MD2XX/candesartan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Update on the treatment and prevention of ischaemic stroke.
Next Document:  Neurological protection provided by candesartan: reviewing the latest study results.